Outlier tests (EMA) [Outliers]

posted by Helmut Homepage – Vienna, Austria, 2010-06-08 17:15 (5452 d 20:05 ago) – Posting: # 5474
Views: 19,718

Dear KR and all,

at last week’s EGA workshop one of the issues was following statement (Section 4.1.10) of the BE-GL

For the acceptance interval to be widened the bioequivalence study must be of a replicate design where it has been demonstrated that the within-subject variability for Cmax of the reference compound in the study is >30%. The applicant should justify that the calculated intra-subject variability is a reliable estimate and that it is not the result of outliers.


No clarification is given in the presentations, but EMA’s panellists agreed thatWell, box plots are a wide field (:vomit: nonparametric by nature!). Keywords: lower/upper adjacent values, inner and outer fence,… Most people would treat values outside the lower/upper quartile ±3× the interquartile range (IQR) as severe outliers (and ±1.5× IQR as mild outliers), but even the method of calculating the quartiles and IQR is not unambigous. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
78 visitors (0 registered, 78 guests [including 47 identified bots]).
Forum time: 13:21 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5